Loading clinical trials...
Loading clinical trials...
The purpose of this trial is to determine the efficacy and safety of Moxifloxacin in comparison to Sulbactam/Ampicillin in the treatment of pulmonary abscesses and aspiration pneumonia.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Bayer
NCT07395310 · Pneumonia, Aspiration
NCT06154486 · Pneumonia, Aspiration, Anesthesia
NCT00005776 · Infant, Newborn, Hypertension, Pulmonary, and more
NCT02301845 · Pneumonia, Aspiration
Mannheim, Baden-Wurttemberg
Nuremberg, Bavaria
Regensburg, Bavaria
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions